Celeste C Finnerty Selected Research

Celeste C Finnerty Research Topics

Disease

94	Burns 01/2020 - 09/2005
19	Wounds and Injuries (Trauma) 01/2020 - 08/2005
17	Infections 12/2017 - 07/2006
16	Sepsis (Septicemia) 01/2018 - 07/2006
13	Inflammation (Inflammations) 01/2020 - 01/2007
9	Insulin Resistance 09/2014 - 09/2007
8	Acute-Phase Reaction 03/2015 - 09/2007
7	Cicatrix (Scar) 01/2020 - 03/2012
7	Critical Illness (Critically Ill) 12/2018 - 09/2007
5	Body Weight (Weight, Body) 01/2018 - 09/2005
4	Hyperglycemia 06/2012 - 03/2008
3	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2018 - 03/2012
3	Multiple Organ Failure (MODS) 05/2014 - 07/2009
3	Wound Infection (Wound Infections) 01/2012 - 02/2007
2	Fibrosis (Cirrhosis) 01/2020 - 12/2017
2	Pain (Aches) 12/2018 - 01/2018
2	Pneumonia (Pneumonitis) 11/2015 - 05/2014
2	Edema (Dropsy) 05/2015 - 09/2007

Drug/Important Bio-Agent (IBA)

21	CytokinesIBA 01/2020 - 07/2006
18	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2007
13	Propranolol (Inderal)FDA LinkGeneric 01/2018 - 03/2007
12	Insulin (Novolin)FDA Link 09/2014 - 09/2005
10	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2007
10	Glucose (Dextrose)FDA LinkGeneric 09/2019 - 08/2010
9	Oxandrolone (Anavar)FDA LinkGeneric 01/2018 - 09/2005
8	Biomarkers (Surrogate Marker)IBA 09/2019 - 09/2010
7	Hormones (Hormone)IBA 01/2016 - 05/2007
5	CatecholaminesIBA 01/2018 - 01/2011
5	Interleukin-8 (Interleukin 8)IBA 03/2015 - 01/2007
5	Interleukin-10 (Interleukin 10)IBA 12/2014 - 01/2007
4	EnzymesIBA 01/2020 - 07/2011
4	salicylhydroxamic acid (SHAM)IBA 01/2020 - 01/2009
4	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2015 - 08/2010
4	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2012 - 09/2005
4	Muscle Proteins (Muscle Protein)IBA 01/2012 - 01/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2007
3	CollagenIBA 01/2020 - 03/2012
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018 - 01/2016
3	LipidsIBA 01/2018 - 01/2013
3	Adenosine Triphosphate (ATP)IBA 01/2018 - 08/2009
3	CalciumIBA 12/2015 - 08/2009
2	Edetic Acid (EDTA)FDA Link 01/2020 - 12/2015
2	MetalsIBA 01/2020 - 12/2015
2	brassIBA 01/2020 - 12/2015
2	Chelating AgentsIBA 01/2020 - 12/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2017 - 01/2009
2	CreatinineIBA 12/2017 - 01/2016
2	Vancomycin FDA LinkGeneric 12/2017 - 04/2016
2	Antiviral Agents (Antivirals)IBA 08/2017 - 02/2017
2	Messenger RNA (mRNA)IBA 01/2017 - 03/2012
2	Oxygen (Dioxygen)IBA 11/2016 - 01/2008
2	Peptides (Polypeptides)IBA 01/2016 - 01/2013
2	Caspase 3 (Caspase-3)IBA 01/2016 - 09/2009
2	IronIBA 01/2016 - 12/2015
2	Blood Glucose (Blood Sugar)IBA 05/2014 - 04/2014
2	Hypoglycemic Agents (Hypoglycemics)IBA 05/2014 - 06/2012
2	Anabolic AgentsIBA 04/2014 - 12/2012
2	Complement System Proteins (Complement)IBA 06/2013 - 09/2010
2	ProteomeIBA 06/2013 - 09/2010
2	Blood Proteins (Serum Proteins)IBA 06/2012 - 09/2010
2	Insulin ReceptorIBA 05/2012 - 02/2012
2	Growth Hormone (Somatotropin)IBA 10/2011 - 08/2005
2	Insulin-Like Growth Factor I (IGF-1)IBA 10/2011 - 09/2005
2	IsotopesIBA 08/2011 - 05/2009
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2009 - 07/2006
2	Interleukin-17 (Interleukin 17)IBA 01/2009 - 09/2008
2	Interleukin-4 (Interleukin 4)IBA 09/2008 - 01/2008
2	Interleukin-5 (Interleukin 5)IBA 09/2008 - 02/2007
2	Interleukin-7 (Interleukin 7)IBA 09/2008 - 01/2008
2	Interleukin-12 (IL 12)IBA 09/2008 - 01/2007
2	Human Growth Hormone (Saizen)FDA LinkGeneric 03/2008 - 09/2005
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020
1	Explosive Agents (Explosives)IBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	MyostatinIBA 01/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	OsteocalcinIBA 09/2019
1	Ethanolamine (Colamine)IBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 12/2018
1	Buprenorphine (Subutex)FDA LinkGeneric 12/2018
1	Hemoglobins (Hemoglobin)IBA 12/2018
1	FibrinIBA 01/2018
1	AcidsIBA 01/2018
1	poly(lactide- co- trimethylenecarbonate- co- epsilon- caprolactone)IBA 01/2018
1	N 30IBA 01/2018

Therapy/Procedure

11	Therapeutics 01/2020 - 03/2008
9	Length of Stay 01/2018 - 02/2007
7	Critical Care (Surgical Intensive Care) 01/2017 - 02/2007
4	Resuscitation 12/2016 - 01/2009
3	Artificial Skin 12/2017 - 01/2015
2	Blood Transfusion (Blood Transfusions) 12/2018 - 02/2007
2	Glycemic Control 01/2016 - 08/2010
2	Mechanical Ventilators (Ventilator) 11/2015 - 01/2008
2	Operative Surgical Procedures 01/2015 - 04/2014
1	Emergency Treatment 01/2020
1	Anesthesia and Analgesia 12/2018
1	Vascular Access Devices (Arterial Line) 11/2018